Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 8, 2013, Pages 785-791

  Lee, S H ^a   Kim, S M ^a   Park, H S ^b   Choi, K M ^a   Cho, G J ^c   Ko, B J ^a   Kim, J H ^d  

^a Korea University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Gurogu Public Health Center   (South Korea)

^d Eulji General Hospital   (South Korea)

Author keywords

25(OH)D; ATP III; BMI; HDL; KMOSES; LDL; Metabolic syndrome; MetS; NCEP; Obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D;

25(OH)D; ADULT TREATMENT PANEL III; ARTICLE; ASIAN; ATP III; BLOOD; BMI; BODY MASS; BODY WEIGHT; CHILD; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KMOSES; MALE; METABOLIC SYNDROME X; METABOLISM; METS; MULTIVARIATE ANALYSIS; NATIONAL CHOLESTEROL EDUCATION PROGRAM; NCEP; NUTRITION; OBESITY; RISK FACTOR; SOUTH KOREA; STATISTICAL MODEL; THE KOREAN METABOLIC DISORDERS AND OBESITY STUDY IN ELEMENTARY SCHOOL CHILDREN; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

25(OH)D; 25-HYDROXYVITAMIN D; ADULT TREATMENT PANEL III; ATP III; BMI; BODY MASS INDEX; HDL; HIGH DENSITY LIPOPROTEIN; KMOSES; LDL; LOW DENSITY LIPOPROTEIN; METABOLIC SYNDROME; METS; NATIONAL CHOLESTEROL EDUCATION PROGRAM; NCEP; OBESITY; THE KOREAN METABOLIC DISORDERS AND OBESITY STUDY IN ELEMENTARY SCHOOL CHILDREN; VITAMIN D;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; OBESITY; REPUBLIC OF KOREA; RISK FACTORS; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

EID: 84880043540     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.04.013     Document Type: Article

References (30)

1. Webber L.S., Srinivasan S.R., Wattigney W.A., Berenson G.S. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991, 133:884-899.
2. Morrison J.A., Friedman L.A., Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007, 120:340-345.
3. Rokholm B., Baker J.L., Sorensen T.I. The levelling off of the obesity epidemic since the year 1999-a review of evidence and perspectives. Obes Rev 2010, 11:835-846.
4. Pacifico L., Anania C., Martino F., Poggiogalle E., Chiarelli F., Arca M., et al. Management of metabolic syndrome in children and adolescents. Nutr Metab Cardiovasc Dis 2011, 21:455-466.
5. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008, 37:113-119.
6. Giovannucci E., Liu Y., Rimm E.B., Hollis B.W., Fuchs C.S., Stampfer M.J., et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451-459.
7. Cantorna M.T., Zhu Y., Froicu M., Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004, 80:1717S-1720S.
8. Moreno L.A., Valtuena J., Perez-Lopez F., Gonzalez-Gross M. Health effects related to low vitamin D concentrations: beyond bone metabolism. Ann Nutr Metab 2011, 59:22-27.
9. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
10. Martini L.A., Wood R.J. Vitamin D status and the metabolic syndrome. Nutr Rev 2006, 64:479-486.
11. Ganji V., Zhang X., Shaikh N., Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr 2011, 94:225-233.
12. Pacifico L., Anania C., Osborn J.F., Ferraro F., Bonci E., Olivero E., et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011, 165:603-611.
13. Choi K.M., Yannakoulia M., Park M.S., Cho G.J., Kim J.H., Lee S.H., et al. Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. Am J Clin Nutr 2011, 93:19-26.
14. Cook S., Weitzman M., Auinger P., Nguyen M., Dietz W.H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003, 157:821-827.
15. Ford E.S., Ajani U.A., Mokdad A.H. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005, 28:878-881.
16. Committee on Health and Statistics Korean Physical Growth standards for children and adolescents 2007, Korea Centers for Disease Control & Prevention, The Korean Pediatric Society, Seoul, Korea.
17. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
18. Choi H.S., Oh H.J., Choi H., Choi W.H., Kim J.G., Kim K.M., et al. Vitamin D insufficiency in Korea-a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011, 96:643-651.
19. Reinehr T., de Sousa G., Toschke A.M., Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child 2007, 92:1067-1072.
20. Seo S.J., Lee H.Y., Lee S.W. The prevalence of the metabolic syndrome in Korean children and adolescents: comparisons of the criteria of Cook etal., Cruz and Goran, and Ferranti, etal. Yonsei Med J 2008, 49:563-572.
21. Rodriguez-Rodriguez E., Navia-Lomban B., Lopez-Sobaler A.M., Ortega R.M. Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren. Eur J Clin Nutr 2010, 64:461-467.
22. Auwerx J., Bouillon R., Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 1992, 12:671-674.
23. Parker J., Hashmi O., Dutton D., Mavrodaris A., Stranges S., Kandala N.B., et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236.
24. Biro F.M., Wien M. Childhood obesity and adult morbidities. Am J Clin Nutr 2010, 91:1499S-1505S.
25. Nelson R.A., Bremer A.A. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord 2010, 8:1-14.
26. Soriano-Guillen L., Hernandez-Garcia B., Pita J., Dominguez-Garrido N., Del Rio-Camacho G., Rovira A. High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur J Endocrinol 2008, 159:R1-R4.
27. Kelly A., Brooks L.J., Dougherty S., Carlow D.C., Zemel B.S. A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child 2011, 96:447-452.
28. Reis J.P., von Muhlen D., Miller E.R., Michos E.D., Appel L.J. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009, 124:e371-e379.
29. Pilz S., Tomaschitz A., Ritz E., Pieber T.R. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009, 6:621-630.
30. Park J., Hilmers D.C., Mendoza J.A., Stuff J.E., Liu Y., Nicklas T.A. Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea. J Korean Med Sci 2010, 25:75-82.